What is Wayovy?
Wegovy is a prescription drug from Novo Nordisk for the treatment of obesity and obesity. It contains the same active ingredient as Ozempic – Semaglutid – but is specifically approved for weight reduction and dosed higher.
The difference to Ozempic:
- Ozempic: Approved for diabetes, max. 2 mg
- Wegovy: Approved for weight reduction, max. 2.4 mg
Wegovy is injected into the skin once a week and has shown average weight loss of about 15% of body weight in studies – significantly more in some patients.
The drug acts via the body's hormone GLP-1, which signals saturation and reduces appetite. Many users report that they are less hungry and are fed up faster.
Active Ingredients & Mechanism of Action
Active ingredient: Semaglutid
Semaglutid imitates the body's hormone GLP-1 (glucagon-like peptides-1):
**1. Appetite regulation in the brain:* * GLP-1 receptors in hypothalamus are activated. This leads to increased saturation and reduced hunger.
**2. Slow gastric emptying:* * The stomach drains more slowly. They feel tired longer and eat less automatically.
**3. Changed food preferences:* * Many users report that they have less desire for fat or sweet food.
The result:
- Significantly reduced appetite
- Smaller portions are enough
- Less cravings
- Automatic lower calorie intake
Study results (STEP studies):
- Average weight loss: 15% of body weight
- About 1/3 of participants lost more than 20%
- Improving blood pressure, cholesterol and blood sugar
Who is it suitable for?
Approved indication:
- BMI ≥ 30 (obesity) OR
- BMI ≥ 27 with at least one weight-related accompanying disease (blood high pressure, type 2 diabetes, increased blood fat, sleep apnea)
Provisions:
- Nutrition and exercise therapy alone were not sufficient
- readiness to change lifestyle
- No contraindications
More suitable:
- Type 1 diabetes
- Pregnancy or planned pregnancy
- History of pancreatitis
- Heavy gastrointestinal diseases
- Medulläres thyroid carcinoma in family
Important: Wegovy is not a lifestyle drug. It is intended for people with medically relevant overweight that endanger their health.
Available Dosages
dosing scheme:
- Weeks 1-4: 0.25 mg once a week
- Weeks 5-8: 0.5 mg once a week
- Weeks 9-12:** 1 mg once a week
- Weeks 13-16:** 1.7 mg once a week
- From week 17: 2.4 mg once a week (maintenance dose)
**Why slow dosing? * * The step-by-step increase significantly reduces gastrointestinal side effects. Nausea and vomiting are common at the beginning, but better with time.
For poor compatibility: If 2.4 mg is not tolerated, it can remain at 1.7 mg.
Available pens: Each dose level has its own prefilled pen with 4 injections for 4 weeks.
How to Take
Application:
- One week, the same weekday
- Subcutaneous injection (under the skin)
- Possible places: belly, thigh, thigh
- Independent meals
Injection technology: 1. Take pen from the refrigerator Two. New needle 3. Form the skin fold and insert the needle 4. Press injection button and hold 6 seconds Five. Remove and remove needle
If you want to change the day: At least 2 days between injections.
Forget dose:
- Within 5 days: Repeat
- After 5 days: omit, next regular dose
Restoration:
- Unopened: fridge (2-8°C)
- After rupture: up to 6 weeks at room temperature or in the refrigerator
Contraindications
Absolute contraindications:
- hypersensitivity to semaglutide
- Medulläres thyroid carcinoma in prehistory
- Multiple endocrine neoplasia type 2 (MEN 2) in the family
- Pregnancy and breastfeeding
Relative contraindications:
- History of pancreatitis
- Heavy kidney failure
- Heavy gastronomic diseases
- Diabetic retinopathy (narrow control)
Preview at:
- Type 2 diabetes with insulin or sulfonylureas (hypoglycemia risk)
- Gallensteinleiden
- Sufficient to depression
Possible Side Effects
Very common (>10%):
- nausea (especially at the beginning)
- diarrhea
- Blocking
- Break.
- stomach pain
Acid (1-10%):
- Headaches
- fatigue
- Blowing
- Sodburning
- Repulse
- Squeeze
- gallstones
Occasionally:
- Increased heart rate
- Reactions at the injection site
- Changes in taste
Selten, but seriously:
- Pancreatitis (strong abdominal pain)
- Heavy allergic reactions
- Acute kidney failure in dehydration
Tips against nausea:
- Slowly dosing
- Small meals
- Avoid fat food
- Eat slowly
- Drink enough
Interactions
Insulin and sulfonylureas:
- Increased hypoglycemia risk in diabetics
- Dose reduction of these drugs often necessary
Oral medicines:
- Slowed gastric emptying can affect absorption
- Relevant for time-critical drugs
Oral contraceptives:
- Additional prevention with strong GI side effects
Warfarin:
- INR controls at therapy start
Frequently Asked Questions
Similar Medications
Is Wayovy right for you?
A licensed doctor will review your information and issue a prescription if suitable. Discreet and secure.
Important Notice
This information does not replace medical advice. If you have questions about your health or the suitability of this medication, please consult a doctor. Read the package leaflet before use.





